118 related articles for article (PubMed ID: 2193496)
1. Beneficial and detrimental effects of lidoflazine in microvascular angina.
Cannon RO; Brush JE; Schenke WH; Tracy CM; Epstein SE
Am J Cardiol; 1990 Jul; 66(1):37-41. PubMed ID: 2193496
[TBL] [Abstract][Full Text] [Related]
2. The effects of lidoflazine on exercise performance and thallium stress scintigraphy in patients with stable angina pectoris.
Shapiro W; Narahara KA; Park J
Circulation; 1982 Jan; 65(1 Pt 2):I43-50. PubMed ID: 6796288
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of lidoflazine in angina pectoris. A long-term double-blind study].
Lehmann H; Hochrein H
Med Klin; 1976 Jan; 71(5):189-96. PubMed ID: 814396
[TBL] [Abstract][Full Text] [Related]
4. Angina pectoris: effects of lidoflazine on exercise tolerance and chest pain.
Jenkins MD; Swallow EA; Abdel-Hadi O; Kidner PH
Am J Cardiol; 1981 Jul; 48(1):140-6. PubMed ID: 7246436
[TBL] [Abstract][Full Text] [Related]
5. Lidoflazine and physical training in the treatment of stable angina pectoris.
Ferguson RJ; Côté P; Bourassa MG; Corbara F
Clin Cardiol; 1979 Dec; 2(6):413-6. PubMed ID: 397017
[TBL] [Abstract][Full Text] [Related]
6. Comparison of exercise testing with studies of coronary flow reserve in patients with microvascular angina.
Cannon RO; Schenke WH; Quyyumi A; Bonow RO; Epstein SE
Circulation; 1991 May; 83(5 Suppl):III77-81. PubMed ID: 2022051
[TBL] [Abstract][Full Text] [Related]
7. The effect of lidoflazine on exercise tolerance in patients with angina pectoris.
Nordstrom LA; Globel FL
Chest; 1978 Jul; 74(1):50-4. PubMed ID: 352634
[TBL] [Abstract][Full Text] [Related]
8. Lidoflazine and propranolol combination treatment in chronic stable angina.
Charlap S; Kimmel B; Berezow J; Molinas S; Strom J; Wexler J; Willens H; Klein N; Pollack S; Frishman WH
Angiology; 1985 Apr; 36(4):240-52. PubMed ID: 4025935
[TBL] [Abstract][Full Text] [Related]
9. Lidoflazine in the management of angina pectoris.
Bloem TJ; Vermeulen A; Reneman RS
Clin Cardiol; 1979 Dec; 2(6):407-12. PubMed ID: 397016
[TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo-controlled evaluation of lidoflazine in patients receiving beta-blocker therapy with propranolol: improvement in anginal symptoms and exercise tolerance with combined drug therapy.
Strauss WE; Parisi AF
Am J Cardiol; 1984 Apr; 53(8):1003-7. PubMed ID: 6422735
[TBL] [Abstract][Full Text] [Related]
11. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction.
Cannon RO; Schenke WH; Leon MB; Rosing DR; Urqhart J; Epstein SE
Circulation; 1987 Jan; 75(1):163-74. PubMed ID: 3791602
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve.
Cannon RO; Watson RM; Rosing DR; Epstein SE
Am J Cardiol; 1985 Aug; 56(4):242-6. PubMed ID: 4025160
[TBL] [Abstract][Full Text] [Related]
13. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain.
Cannon RO; Cunnion RE; Parrillo JE; Palmeri ST; Tucker EE; Schenke WH; Epstein SE
J Am Coll Cardiol; 1987 Dec; 10(6):1190-200. PubMed ID: 3680786
[TBL] [Abstract][Full Text] [Related]
14. [Non-invasive examination of cardiac hemodynamics in an anginal coronary syndrome after long term treatment with lidoflazine].
Dvorák I; Zemánková J; Bravený P; Blaha M; Dvorák M; Sedá L; Havlát F
Vnitr Lek; 1981 Apr; 27(4):338-44. PubMed ID: 7027603
[No Abstract] [Full Text] [Related]
15. Lidoflazine: double-blind trial of a new coronary vasodilator in angina pectoris.
Brantmark B; Egelius N; Fabricius E; Jemt M; Palmborg G; Philipson J; Rönnegård N
Eur J Clin Pharmacol; 1973 Oct; 6(3):156-62. PubMed ID: 4202654
[No Abstract] [Full Text] [Related]
16. Improved exercise myocardial perfusion during lidoflazine therapy.
Shapiro W; Narahara KA; Park J
Angiology; 1983 Nov; 34(11):705-10. PubMed ID: 6638605
[TBL] [Abstract][Full Text] [Related]
17. Vasotonic angina: a spectrum of ischemic syndromes involving functional abnormalities of the epicardial and microvascular coronary circulation.
Bugiardini R; Pozzati A; Ottani F; Morgagni GL; Puddu P
J Am Coll Cardiol; 1993 Aug; 22(2):417-25. PubMed ID: 8166784
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of lidoflazine as an anti-anginal drug.
Vohra JK; Sloman JG
Cardiology; 1973; 58(4):209-19. PubMed ID: 4206284
[No Abstract] [Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina.
Kaski JC; Rosano G; Gavrielides S; Chen L
J Am Coll Cardiol; 1994 Mar; 23(3):652-7. PubMed ID: 8113548
[TBL] [Abstract][Full Text] [Related]
20. Ventricular arrhythmias associated with lidoflazine: side-effects observed in a randomized trial.
Hanley SP; Hampton JR
Eur Heart J; 1983 Dec; 4(12):889-93. PubMed ID: 6363079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
